Cara Therapeutics
CARA
#10282
Rank
ยฃ6.13 M
Marketcap
ยฃ4.02
Share price
-2.56%
Change (1 day)
15.85%
Change (1 year)

Earnings for Cara Therapeutics (CARA)

Earnings in 2024 (TTM): -ยฃ49.25 Million

According to Cara Therapeutics 's latest financial reports the company's current earnings are ยฃ7.13 Million. , an increase over its 2023 earnings that were of -ยฃ87.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cara Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -ยฃ47.49 Million-45.49%
2023 -ยฃ87.12 Million31.6%
2022 -ยฃ66.2 Million-1.74%
2021 -ยฃ67.37 Million-1754.28%
2020 ยฃ4.07 M-104.82%
2019 -ยฃ84.46 Million44.32%
2018 -ยฃ58.52 Million30.09%
2017 -ยฃ44.99 Million1.86%
2016 -ยฃ44.17 Million131.86%
2015 -ยฃ19.05 Million39.38%
2014 -ยฃ13.67 Million9120.41%
2013 -ยฃ0.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ24.49 B-51,692.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ8.96 B-18,975.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-ยฃ23.49 Million-50.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
ยฃ2.84 M-105.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-ยฃ60.04 Million 26.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-ยฃ0.21 Billion 332.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-ยฃ7.78 Million-83.62%๐Ÿ‡บ๐Ÿ‡ธ USA